Filing Details

Accession Number:
0001466049-11-000069
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-09-21 16:54:45
Reporting Period:
2011-09-19
Filing Date:
2011-09-21
Accepted Time:
2011-09-21 16:54:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1322505 Biodel Inc BIOD Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1304170 Solomon Steiner C/O Biodel Inc.
100 Saw Mill Road
Danbury CT 06810
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-09-19 190,700 $1.19 1,811,622 No 4 S Direct
Common Stock Disposition 2011-09-20 82,723 $1.17 1,728,899 No 4 S Direct
Common Stock Disposition 2011-09-21 43,094 $1.15 1,685,805 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $1.19 to $1.22. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to proivde upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the tranaction was reflected.
  2. This transaction was executed in multiple trades at prices ranging from $1.15 to $1.21 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to proivde upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the tranaction was reflected.
  3. The sales reported in this transaction were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2011. This transaction was executed in multiple trades at prices ranging from $1.13 to $1.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to proivde upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the tranaction was reflected.
  4. The amount shown represents shares of the Issuer beneficially owned by Steiner Ventures, LLC. which shares may be deemed attributable to the Reporting Person because the Reporting Person is the sole managing member of Steiner Ventures, LL. The Reporting Person disclaims beneificial ownership except to the extent of his pecuniary interest therein.